About Carlos Bonilla

This author has not yet filled in any details.
So far Carlos Bonilla has created 20 blog entries.

New Orphan Drug Playing Field Requires Change in Tactics for Pharma Companies

Orphan drugs make up a growing slice of the pharmaceutical pipeline, with a significant share of new drug approvals, and payers are taking notice of their increasing market numbers and ultra-expensive price tags. Precision's Jeremy Schafer, PharmD, MBA, discusses how manufacturers may adjust their promotion of orphan drugs to ensure continued market access.

LEARN MORE

New Orphan Drug Playing Field Requires Change in Tactics for Pharma Companies2020-07-17T12:01:12-04:00

Pharma Manufacturers Could See Better Adherence, Outcomes With Focus on SDOH

How much of a role can pharmaceutical manufacturers play in the social determinants of health? Industry experts, Maureen Hennessey, PhD, and Dominic Galante, MD, discuss how much they can stand to gain in medication adherence and outcomes from partnering with other industry stakeholders and programs around the issue.

LEARN MORE

Pharma Manufacturers Could See Better Adherence, Outcomes With Focus on SDOH2020-07-17T12:01:17-04:00

Why the dance between manufacturers and PBMs continues

Love them or hate them, copay accumulator programs probably aren't going away anytime soon. We'll have to see how the market evolves over time with manufacturers and payers adapting these programs to counteract each other. The dance continues!

LEARN MORE

Why the dance between manufacturers and PBMs continues2020-07-17T11:44:17-04:00